Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization

Fertility and Sterility

Volumn 105, Issue 3, 2016, Pages 791-797.e2

  Sterling, Lynn ^a   Liu, Jennifer ^a   Okun, Nan ^b   Sakhuja, Anamika ^a   Sierra, Sony ^a,c   Greenblatt, Ellen ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c Lifequest Centre for Reproductive Medicine   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diabetes (gestational); hypertension (pregnancy induced); in vitro fertilization; polycystic ovary syndrome; pregnancy outcomes

Indexed keywords

ADULT; ANTEPARTUM HEMORRHAGE; CESAREAN SECTION; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; FETUS DEATH; HIGH RISK PREGNANCY; HUMAN; LARGE FOR GESTATIONAL AGE; LOW BIRTH WEIGHT; MACROSOMIA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PERINATAL MORTALITY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SMALL FOR DATE INFANT; TIME TO PREGNANCY; UTERINE CERVIX CERCLAGE; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; COMPLICATION; FERTILITY; INFERTILITY, FEMALE; LIVE BIRTH; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY RATE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

ADULT; CHI-SQUARE DISTRIBUTION; FEMALE; FERTILITY; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; LIVE BIRTH; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY RATE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84959534373     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2015.11.019     Document Type: Article

References (43)

1. T.D. Vause, A.P. Cheung, S. Sierra, P. Claman, J. Graham, J.A. Guillemin, and et al. Ovulation induction in polycystic ovary syndrome J Obstet Gynaecol Can 32 2010 495 502
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 2004 19 25
3. A. Gambineri, C. Pelusi, V. Vicennati, U. Pagotto, and R. Pasquali Obesity and the polycystic ovary syndrome Int J Obes Relat Metabol Disord 26 2002 883 896
4. F. Ovalle, and R. Azziz Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus Fertil Steril 77 2002 1095 1105
5. L. Moran, and H. Teede Metabolic features of the reproductive phenotypes of polycystic ovary syndrome Hum Reprod Update 15 2009 477 488
6. C.M. Boomsma, M.J. Eijkemans, E.G. Hughes, G.H. Visser, B.C. Fauser, and N.S. Macklon A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome Hum Reprod Update 12 2006 673 683
7. L.E. Kjerulff, L. Sanchez-Ramos, and D. Duffy Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis Am J Obstet Gynecol 204 2011 558.e1 558.e6
8. J.Z. Qin, L.H. Pang, M.J. Li, X.J. Fan, R.D. Huang, and H.Y. Chen Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis Reprod Biol Endocrinol 11 2013 56
9. Park A. CML HealthCare laboratory reference ranges manual. Available at: http://cmlhealthcare.com/wp-content/uploads/2014/06/CML-Reference-Ranges.pdf. Accessed March 15, 2015.
10. R. Azziz, E. Carmina, D. Dewailly, E. Diamanti-Kandarakis, H.F. Escobar-Morreale, W. Futterweit, and et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline J Clin Endocrinol Metab 91 2006 4237 4245
11. Farquharson Roy, Exalto Niek, Bender-Atik Ruth, Hepworth-Jones Barbara, Doyle Pat, Kirk Emma, and et al. Investigation of recurrent miscarriage Early pregnancy 2010 Cambridge University Press Cambridge, UK 60
12. D. Shmorgun, and P. Claman The diagnosis and management of ovarian hyperstimulation syndrome J Obstetr Gynaecol Can 33 2011 1156 1162
13. D. Thompson, H. Berger, D. Feig, R. Gagnon, T. Kader, E. Keely, and et al. Diabetes and pregnancy. Can J Diabetes 37 Suppl 1 2013 S168 S183
14. A.L. Tranquilli, G. Dekker, L. Magee, J. Roberts, B.M. Sibai, W. Steyn, and et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP Pregnancy Hypertens 4 2014 97 104
15. T.R. Fenton, and J.H. Kim A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants BMC Pediatr 13 2013 59
16. H.L. Wan, P.W. Hui, H.W. Li, and E.H. Ng Obstetric outcomes in women with polycystic ovary syndrome and isolated polycystic ovaries undergoing in vitro fertilization: a retrospective cohort analysis J Matern Fetal Neonatal Med 28 2015 475 478
17. K.A. Toulis, D.G. Goulis, E.M. Kolibianakis, C.A. Venetis, B.C. Tarlatzis, and I. Papadimas Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis Fertil Steril 92 2009 667 677
18. A.R. Han, H.O. Kim, S.W. Cha, C.W. Park, J.Y. Kim, K.M. Yang, and et al. Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study Clin Exp Reprod Med 38 2011 103
19. L. Haakova, D. Cibula, K. Rezabek, M. Hill, M. Fanta, and J. Zivny Pregnancy outcome in women with PCOS and in controls matched by age and weight Hum Reprod 18 2003 1438 1441
20. B. Vollenhoven, S. Clark, G. Kovacs, H. Burger, and D. Healy Prevalence of gestational diabetes mellitus in polycystic ovarian syndrome (PCOS) patients pregnant after ovulation induction with gonadotrophins Aust N Z J Obstet Gynaecol 40 2000 54 58
21. S. Hu, A. Leonard, A. Seifalian, and P. Hardiman Vascular dysfunction during pregnancy in women with polycystic ovary syndrome Hum Reprod 22 2007 1532 1539
22. M.J. Chen, W.S. Yang, J.H. Yang, C.L. Chen, H.N. Ho, and Y.S. Yang Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome Hypertension 49 2007 1442 1447
23. K.V. Naver, J. Grinsted, S.O. Larsen, P.L. Hedley, F.S. Jorgensen, M. Christiansen, and et al. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia BJOG 121 2014 575 581
24. N. Roos, H. Kieler, L. Sahlin, G. Ekman-Ordeberg, H. Falconer, and O. Stephansson Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study BMJ 343 2011 d6309
25. T. Sir-Petermann, C. Hitchsfeld, M. Maliqueo, E. Codner, B. Echiburu, R. Gazitua, and et al. Birth weight in offspring of mothers with polycystic ovarian syndrome Hum Reprod 20 2005 2122 2126
26. J.M. Baeten, E.A. Bukusi, and M. Lambe Pregnancy complications and outcomes among overweight and obese nulliparous women Am J Public Health 91 2001 436 440
27. P.J. Surkan, C.C. Hsieh, A.L. Johansson, P.W. Dickman, and S. Cnattingius Reasons for increasing trends in large for gestational age births Obstet Gynecol 104 2004 720 726
28. V. De Fréne, S. Vansteelandt, G. T'Sjoen, J. Gerris, S. Somers, L. Vercruysse, and et al. A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome Hum Reprod 29 2014 2333 2338
29. C.M. Boomsma, B.C. Fauser, and N.S. Macklon Pregnancy complications in women with polycystic ovary syndrome Semin Reprod Med 26 2008 72 84
30. D.J. Jakubowicz, M.J. Iuorno, S. Jakubowicz, K.A. Roberts, and J.E. Nestler Effects of metformin on early pregnancy loss in the polycystic ovary syndrome J Clin Endocrinol Metab 87 2002 524 529
31. L. Liu, X. Tong, L. Jiang, T.C. Li, F. Zhou, and S. Zhang A comparison of the miscarriage rate between women with and without polycystic ovarian syndrome undergoing IVF treatment Eur J Obstet Gynecol Reprod Biol 176 2014 178 182
32. R. Homburg, N.A. Armar, A. Eshel, J. Adams, and H.S. Jacobs Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome BMJ 297 1988 1024 1026
33. L. Tian, H. Shen, Q. Lu, R.J. Norman, and J. Wang Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment J Clin Endocrinol Metab 92 2007 1430 1433
34. M.A. Okon, S.M. Laird, E.M. Tuckerman, and T.C. Li Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function Fertil Steril 69 1998 682 690
35. J.X. Wang, R.J. Norman, and A.J. Wilcox Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technology Hum Reprod 19 2004 272 277
36. ESHRE Capri Workshop Group Nutrition and reproduction in women Hum Reprod Update 12 2006 193 207
37. Society for Assisted Reproductive Technology. Society for Assisted Reproductive Technology database on IVF cycles. Available at: https://www.sartcorsonline.com/rptCSR-PublicMultYear.aspx?ClinicPKID=0. Accessed March 15, 2015.
38. Joint Society of Obstetricians and Gynaecologists of Canada-Canadian Fertility and Andrology Society Clinical Practice Guidelines Committee D. Shmorgun, P. Claman, M. Gysler, R. Hemmings, A.P. Cheung, and et al. The diagnosis and management of ovarian hyperstimulation syndrome: no. 268, November 2011 Int J Gynaecol Obstet 116 2012 268 273
39. S. Pandey, A. Shetty, M. Hamilton, S. Bhattacharya, and A. Maheshwari Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis Hum Reprod Update 18 2012 485 503
40. Z. Li, Y.A. Wang, W. Ledger, D.H. Edgar, and E.A. Sullivan Clinical outcomes following cryopreservation of blastocysts by vitrification or slow freezing: a population-based cohort study Hum Reprod 29 2014 2794 2801
41. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 37 Suppl 1 2014 S81 S90
42. National Institute for Health and Clinical Excellence Clinical guideline 107: hypertension in pregnancy: the management of hypertensive disorders during pregnancy 2011 NICE Manchester, UK
43. N. Sattar, and I.A. Greer Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 325 2002 157 160